Barclays Upgrades Dr. Reddy's Laboratories (RDY) to Overweight
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Price: $70.92 --0%
Rating Summary:
8 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 3
Rating Summary:
8 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 3
Join SI Premium – FREE
Barclays upgraded Dr. Reddy's Laboratories (NYSE: RDY) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $38.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades UDR, Inc. (UDR) to Buy
- Wells Fargo Upgrades Packaging Corp. of America (PKG) to Overweight
- Goldman Sachs Upgrades The TJX Companies (TJX) to Buy, 'best-in-class operator'
Create E-mail Alert Related Categories
UpgradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
